Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free VRCA Stock Alerts

Verrica Pharmaceuticals (VRCA) Short Interest Ratio & Short Volume

Verrica Pharmaceuticals logo
$7.87 -0.56 (-6.65%)
As of 01:05 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Verrica Pharmaceuticals Short Interest Overview

As of April 15, 2026, Verrica Pharmaceuticals (VRCA) had a short interest of 581,329 shares sold short, representing 7.36% of the public float. This marks a 16.79% increase in short interest since the prior report. The short interest ratio (days to cover) is 6.8, meaning it would take 6.8 days of the average trading volume of 127,846 shares to cover all short positions.

Current Short Interest
581,329 shares
Previous Short Interest
497,753 shares
Change Vs. Previous Month
16.79%
Dollar Volume Sold Short
$3.44 million
Short Interest Ratio
6.8 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
17,180,000 shares
Short Percent of Float
7.36%
Today's Trading Volume
26,577 shares
Average Trading Volume
127,846 shares
Today's Volume Vs. Average
21%
Short Selling Verrica Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VRCA Short Interest Over Time

VRCA Days to Cover Over Time

VRCA Percentage of Float Shorted Over Time

Verrica Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2026581,329 shares $3.44 million +16.8%7.4%6.81 $5.91
3/31/2026497,753 shares $2.63 million +4.0%6.3%3.94 $5.29
3/13/2026478,579 shares $2.92 million +18.2%6.1%3.16 $6.11
2/27/2026405,005 shares $2.22 million +5.3%5.5%3.89 $5.47
2/13/2026384,580 shares $2.19 million +13.8%5.2%2.38 $5.69
1/30/2026338,059 shares $2.38 million +13.1%4.6%2.49 $7.03
1/15/2026299,006 shares $2.28 million +2.3%4.1%1.89 $7.61
12/31/2025292,263 shares $2.43 million -23.2%4.0%1.37 $8.31
12/15/2025380,561 shares $2.88 million -26.2%5.2%1.38 $7.56
11/28/2025515,613 shares $4.53 million +15.4%11.8%0.89 $8.79
11/14/2025446,691 shares $1.76 million +6.4%10.2%6.84 $3.93
10/31/2025419,718 shares $1.52 million +38.9%9.7%1.13 $3.61
10/15/2025302,200 shares $1.24 million -29.5%2.5%1.1 $4.10
9/30/2025428,400 shares $1.85 million +152.2%10.6%2 $4.31
9/15/2025169,900 shares $839.31 thousand +2.7%4.2%0.9 $4.94
8/31/2025165,500 shares $925.15 thousand +12.8%4.1%3.1 $5.59
8/15/2025146,700 shares $874.33 thousand -2.1%2.8%2.8 $5.96
7/31/2025149,800 shares $843.37 thousand -32.3%3.0%3.2 $5.63
7/15/2025221,200 shares $1.77 million +1,164.0%N/A5.2 $7.98
6/30/202517,500 shares $9.28 thousand -99.4%0.4%0.1 $0.53
6/15/20252,970,000 shares $1.85 million +30.8%7.0%9.2 $0.62
5/31/20252,270,000 shares $1.14 million -27.9%8.7%5.9 $0.50
5/15/20253,150,000 shares $2.02 million +16.2%12.0%7.9 $0.64
4/30/20252,710,000 shares $1.26 million -4.6%N/A6.9 $0.46
4/15/20252,840,000 shares $1.40 million -0.4%10.9%7.3 $0.49
3/31/20252,850,000 shares $1.26 million +28.4%10.9%7 $0.44
3/15/20252,220,000 shares $1.19 million +9.4%8.5%4.9 $0.54
2/28/20252,030,000 shares $1.32 million +2.0%7.8%4.6 $0.65
2/15/20251,990,000 shares $1.47 million -1.5%7.6%3.8 $0.74
1/31/20252,020,000 shares $1.31 million +11.0%N/A3.3 $0.65
1/15/20251,820,000 shares $1.21 million -6.7%N/A2.6 $0.66
12/31/20241,950,000 shares $1.37 million -2.5%N/A2.7 $0.70
12/15/20242,000,000 shares $1.52 million -34.2%N/A2.2 $0.76
11/30/20243,040,000 shares $3.89 million -32.6%N/A3.5 $1.28
11/15/20244,510,000 shares $3.76 million +3.2%16.6%4.7 $0.83
10/31/20244,370,000 shares $6.12 million -3.5%16.1%4 $1.40
10/15/20244,530,000 shares $6.30 million +24.8%17.4%4.7 $1.39
9/30/20243,630,000 shares $5.26 million +11.7%13.9%3.9 $1.45
9/15/20243,250,000 shares $6.40 million +9.1%12.5%4.7 $1.97
8/31/20242,980,000 shares $7.00 million -28.9%11.5%4.6 $2.35
8/15/20244,190,000 shares $12.19 million +13.6%16.2%9.3 $2.91
7/31/20243,690,000 shares $24.32 million -6.8%14.3%15.4 $6.59
7/15/20243,960,000 shares $33.15 million +1.3%15.4%17.1 $8.37
6/30/20243,910,000 shares $28.50 million +9.5%15.2%18 $7.29
6/15/20243,570,000 shares $28.99 million +0.9%13.9%16.5 $8.12
5/31/20243,540,000 shares $30.13 million -7.8%13.7%18.2 $8.51
5/15/20243,840,000 shares $34.94 million +6.1%14.9%20.2 $9.10
4/30/20243,620,000 shares $25.21 million -5.7%14.1%23.6 $6.97
4/15/20243,840,000 shares $26.57 million -8.1%15.1%28.3 $6.92
3/31/20244,180,000 shares $24.75 million -5.0%16.5%28.2 $5.92
3/15/20244,400,000 shares $21.12 million -0.7%17.4%22.4 $4.80
2/29/20244,430,000 shares $23.35 million +1.1%17.4%4.1 $5.27
2/15/20244,380,000 shares $24.35 million -1.1%17.3%4.1 $5.56
1/31/20244,430,000 shares $25.03 million -20.2%17.7%4.1 $5.65
1/15/20245,550,000 shares $31.75 million +5.3%22.1%5.1 $5.72
12/31/20235,270,000 shares $38.58 million +44.4%21.0%4.9 $7.32
12/15/20233,650,000 shares $22.23 million -8.5%14.6%3.4 $6.09
11/30/20233,990,000 shares $14.68 million -6.3%15.9%25 $3.68
11/15/20234,260,000 shares $13.50 million +1.2%17.0%23.9 $3.17
10/31/20234,210,000 shares $15.49 million -2.3%16.7%21.7 $3.68
10/15/20234,310,000 shares $15.73 million -3.8%17.1%15.1 $3.65
9/30/20234,480,000 shares $17.40 million -9.3%17.8%11.8 $3.89
9/15/20234,940,000 shares $20.01 million +1.9%19.6%12.6 $4.05
8/31/20234,850,000 shares $22.07 million +7.5%19.3%11.5 $4.55
8/15/20234,510,000 shares $22.50 million +11.1%17.8%11.1 $4.99
7/31/20234,060,000 shares $23.71 million +34.4%16.0%10.7 $5.84
7/15/20233,020,000 shares $20.20 million +3.8%12.0%9.4 $6.69
6/30/20232,910,000 shares $16.79 million +33.5%11.5%13.3 $5.77
6/15/20232,180,000 shares $13.67 million +6.9%8.6%10.6 $6.27
5/31/20232,040,000 shares $11.57 million +14.6%8.1%13.4 $5.67
5/15/20231,780,000 shares $10.86 million +21.1%7.1%10.9 $6.10
4/30/20231,470,000 shares $9.07 million +55.7%5.9%7.6 $6.17
4/15/2023944,100 shares $5.85 million +60.7%3.8%4.9 $6.20
3/31/2023587,500 shares $3.82 million +94.8%2.4%3 $6.50
3/15/2023301,600 shares $2.01 million +24.8%1.2%1.7 $6.65
2/28/2023241,600 shares $1.87 million -7.5%1.0%1.4 $7.75
2/15/2023261,200 shares $1.97 million +12.1%1.1%1.6 $7.54
1/31/2023233,000 shares $1.08 million -50.7%1.0%1.7 $4.62
1/15/2023472,500 shares $2.29 million -18.4%2.0%4.2 $4.85
12/30/2022579,300 shares $1.59 million -7.9%2.4%5.9 $2.75
12/15/2022629,000 shares $1.98 million -4.2%2.6%8.1 $3.14
11/30/2022656,300 shares $2.13 million -5.7%2.7%6.6 $3.25
11/15/2022695,800 shares $1.59 million +6.0%2.9%7.1 $2.28
10/31/2022656,300 shares $1.63 million +7.0%2.7%6.5 $2.49
10/15/2022613,200 shares $1.67 million -1.9%2.6%5.7 $2.73
9/30/2022625,100 shares $1.83 million -19.6%2.6%4.5 $2.92
9/15/2022777,900 shares $2.96 million -9.8%3.2%2.4 $3.80
8/31/2022862,400 shares $3.38 million -10.1%3.7%2.6 $3.92
8/15/2022958,800 shares $3.75 million -8.7%4.1%1.8 $3.91
7/31/20221,050,000 shares $3.31 million +5.0%7.0%1.9 $3.15
7/15/20221,000,000 shares $3.21 million -16.7%6.6%1.8 $3.21
6/30/20221,200,000 shares $2.30 million -30.2%8.0%2.2 $1.92
6/15/20221,720,000 shares $3.82 million -5.0%11.1%4.6 $2.22
5/31/20221,810,000 shares $3.49 million -0.6%11.7%5.6 $1.93
5/15/20221,820,000 shares $10.30 million +3.4%11.7%15.3 $5.66
4/30/20221,760,000 shares $11.56 million +8.6%11.3%22.4 $6.57
4/15/20221,620,000 shares $12.83 million +5.2%10.4%23.9 $7.92
3/31/20221,540,000 shares $12.49 million +0.7%9.9%26.6 $8.11
3/15/20221,530,000 shares $12.19 million +2.0%9.9%27 $7.97
2/28/20221,500,000 shares $12.57 million -6.3%9.7%24 $8.38
2/15/20221,600,000 shares $13.41 million +2.6%10.3%23.8 $8.38
1/31/20221,560,000 shares $12.78 million +6.9%11.1%24.5 $8.19
1/15/20221,460,000 shares $12.15 million +2.1%11.1%23.3 $8.32
12/31/20211,430,000 shares $13.10 million +2.1%10.9%23.4 $9.16
12/15/20211,400,000 shares $13.19 million +6.9%10.6%20.5 $9.42
11/30/20211,310,000 shares $13.56 million No Change9.9%11.5 $10.35
11/15/20211,310,000 shares $15.77 million -0.8%9.9%10.6 $12.04
10/29/20211,320,000 shares $16.62 million -2.9%10.0%10.5 $12.59
10/15/20211,360,000 shares $18.17 million -8.1%10.3%11 $13.36
9/30/20211,480,000 shares $18.50 million -21.3%11.2%12.1 $12.50
9/15/20211,880,000 shares $22.15 million -2.1%14.2%15.4 $11.78
8/31/20211,920,000 shares $21.50 million -3.0%14.6%24.6 $11.20
8/13/20211,980,000 shares $21.27 million -2.9%15.1%24.9 $10.74
7/30/20212,040,000 shares $21.83 million No Change15.6%24.2 $10.70
7/15/20212,040,000 shares $21.11 million -1.5%14.0%22.3 $10.35
6/30/20212,070,000 shares $23.39 million +2.0%14.2%21.1 $11.30
6/15/20212,030,000 shares $23.97 million +24.5%13.9%18.6 $11.81
5/28/20211,630,000 shares $18.35 million +8.0%11.1%14.4 $11.26
5/14/20211,510,000 shares $17.62 million +1.3%10.3%14.4 $11.67

VRCA Short Interest - Frequently Asked Questions

What is Verrica Pharmaceuticals' current short interest?

Short interest is the volume of Verrica Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 581,329 shares of VRCA short. 7.36% of Verrica Pharmaceuticals' shares are currently sold short. Learn More on Verrica Pharmaceuticals' current short interest.

What is a good short interest ratio for Verrica Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRCA shares currently have a short interest ratio of 6.8. Learn More on Verrica Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Verrica Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.36% of Verrica Pharmaceuticals' floating shares are currently sold short.

Is Verrica Pharmaceuticals' short interest increasing or decreasing?

Verrica Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 581,329 shares, an increase of 16.8% from the previous total of 497,753 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Verrica Pharmaceuticals' short interest compare to its competitors?

7.36% of Verrica Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Verrica Pharmaceuticals: Larimar Therapeutics, Inc. (7.39%), Candel Therapeutics, Inc. (24.66%), Climb Bio, Inc. (3.40%), Aura Biosciences, Inc. (3.35%), REGENXBIO Inc. (15.43%), Eupraxia Pharmaceuticals Inc. (4.25%), Benitec Biopharma Limited (6.93%), PureTech Health PLC Sponsored ADR (0.07%), Atea Pharmaceuticals, Inc. (11.78%), Neurogene Inc. (29.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Verrica Pharmaceuticals stock?

Short selling VRCA is an investing strategy that aims to generate trading profit from Verrica Pharmaceuticals as its price is falling. VRCA shares are trading down $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Verrica Pharmaceuticals?

A short squeeze for Verrica Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VRCA, which in turn drives the price of the stock up even further.

How often is Verrica Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRCA, twice per month. The most recent reporting period available is April, 15 2026.

What do VRCA's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like VRCA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:VRCA) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel